Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

November 30, 1999

Primary Completion Date

January 31, 2001

Study Completion Date

August 31, 2003

Conditions
Lung Cancer
Interventions
DRUG

oxaliplatin

DRUG

paclitaxel

Trial Locations (11)

43210

Arthur G. James Cancer Hospital - Ohio State University, Columbus

46617

Michiana Hematology/Oncology P.C., South Bend

60068

Lutheran General Cancer Care Center, Park Ridge

60201

Evanston Northwestern Health Care, Evanston

60612

University of Illinois at Chicago, Chicago

60637

University of Chicago Cancer Research Center, Chicago

60640

Louis A. Weiss Memorial Hospital, Chicago

61602

Oncology/Hematology Associates of Central Illinois, P.C., Peoria

62526

Cancer Care Specialists of Central Illinois, S.C., Decatur

62701

Central Illinois Hematology Oncology Center, Springfield

46885-5099

Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Chicago

OTHER